Zhongke Jingyan Health Industry Group
The group owns its self-developed platform, a platform for the transformation of scientific and technological achievements, and a sales platform.
Focus on Zhongke Jingyan
Focus on Zhongke Jingyan
A supramolecular hydrogel with DNA base pair crosslinking
The human genome contains approximately 3.16 billion DNA base pairs. The preparation process of cross-linked supramolecular hydrogels has high biocompatibility with the human genome and has characteristics such as stress response and self-healing. Compared with the ordinary preparation process of similar products, the safety and direct efficacy are at least 10 times higher. At the same time, it is biocompatible with the skin without irritation, and is environmentally friendly, non-sensitizing, and has a very low allergy rate. It is safe, comfortable, and can be used for a long time.
The human genome contains approximately 3.16 billion DNA base pairs. The preparation process of cross-linked supramolecular hydrogels has high biocompatibility with the human genome and has characteristics such as stress response and self-healing. Compared with the ordinary preparation process of similar products, the safety and direct efficacy are at least 10 times higher. At the same time, it is biocompatible with the skin without irritation, and is environmentally friendly, non-sensitizing, and has a very low allergy rate. It is safe, comfortable, and can be used for a long time.
New microneedle transdermal absorption formulation technology
Microneedle technology refers to a new type of transdermal absorption preparation in the form of a patch that uses microneedle tips containing medication to administer medication to the body by adhering closely to the skin.
Characteristics of microneedle preparations
☑ Able to transdermally deliver water-soluble polymer drugs
☑ Painless administration, no bleeding
☑ Simple and safe administration method, capable of self-administration
☑ Solid preparation, easy to transport and store
☑ Reduce the cost of industrial waste from injection needles
☑ Able to ingest vaccines on a large scale during outbreaks
Microneedle technology refers to a new type of transdermal absorption preparation in the form of a patch that uses microneedle tips containing medication to administer medication to the body by adhering closely to the skin.
Characteristics of microneedle preparations
☑ Able to transdermally deliver water-soluble polymer drugs
☑ Painless administration, no bleeding
☑ Simple and safe administration method, capable of self-administration
☑ Solid preparation, easy to transport and store
☑ Reduce the cost of industrial waste from injection needles
☑ Able to ingest vaccines on a large scale during outbreaks
The group owns independent R&D platforms, technology transformation platforms, and sales platforms.
Zhongke Jingyan Health Industry Group
Jilin Zhongke Jingyan Health Industry Group, founded in 2013, initially engaged in clinical trials of drugs. With the development of the company, it has gradually grown into a large health industry group integrating health food, drug R&D, drug clinical trials, and medical device R&D and sales.
The group owns independent R&D platforms, technology transformation platforms, and sales platforms. It can independently develop and participate in the R&D of health food, pharmaceuticals, and medical device projects.
Founded in
Applying for various patents
Approved Number
The group owns independent R&D platforms, technology transformation platforms, and sales platforms.
Blog
